Biotech | November 05, 2021
Novavax files emergency use listing with WHO for Covid-19 vaccine
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Filing marks first protein-based vaccine submitted to MHRA for authorization
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Subscribe To Our Newsletter & Stay Updated
